Workers transfer containers of the COVID-19 vaccine in Maputo, Mozambique, on June 30, 2021. Mozambique on Wednesday received 500,000 doses of COVID-19 vaccine purchased by the country's private sector in coordination with the government. The procurement of the 500,000 doses of the Sinopharm COVID-19 vaccine, an inactivated vaccine called SARS-CoV-2 Vaccine (Vero Cell), is part of the local initiative "United for the vaccine against COVID-19" (UNIVAX), of which, 139,000 doses will be offered to the Mozambican government. (Photo by Edson Manjate/Xinhua)

Workers transfer containers of the COVID-19 vaccine in Maputo, Mozambique, on June 30, 2021. Mozambique on Wednesday received 500,000 doses of COVID-19 vaccine purchased by the country's private sector in coordination with the government. The procurement of the 500,000 doses of the Sinopharm COVID-19 vaccine, an inactivated vaccine called SARS-CoV-2 Vaccine (Vero Cell), is part of the local initiative "United for the vaccine against COVID-19" (UNIVAX), of which, 139,000 doses will be offered to the Mozambican government. (Photo by Edson Manjate/Xinhua)

Mozambican Minister of Health Armindo Tiago (L) stands in front of containers of the COVID-19 vaccine in Maputo, Mozambique, on June 30, 2021. Mozambique on Wednesday received 500,000 doses of COVID-19 vaccine purchased by the country's private sector in coordination with the government. The procurement of the 500,000 doses of the Sinopharm COVID-19 vaccine, an inactivated vaccine called SARS-CoV-2 Vaccine (Vero Cell), is part of the local initiative "United for the vaccine against COVID-19" (UNIVAX), of which, 139,000 doses will be offered to the Mozambican government. (Photo by Edson Manjate/Xinhua)